Saturday, 21 February 2026
  
Login

Australia's most trusted
source of pharma news

Saturday, 21 February 2026
News

Obesity battle, now a war of words?

 Posted 20 February 2025 PM

As the high stakes contest to win the multibillion-dollar obesity and diabetes market rages across several fronts, one combatant is ahead in a key battleground - control of the narrative.

“If you ask most people who’s winning hearts and minds right now, their instinctive answer is Lilly,” according to US-based healthcare communications expert, Kieran Fagan. And having analysed the messages that Eli Lilly and Novo Nordisk are sending about their products, Fagan says the data backs that up.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (14)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (4)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.